Dr. Louis R. Manara

Dehydroepiandrosterone (DHEA) has been found to improve pregnancy rates in patients with diminished ovarian reserve.  However, the question of whether older patients with normal ovarian reserve will also benefit from DHEA supplementation, has not been addressed.  A recent study conducted at the University of Bari School of Medicine in Italy suggests that miscarriage rates are lower and IVF pregnancy rates are higher in patients treated with DHEA supplements before undergoing IVF treatment.

The American Society For Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE) held a combined meeting in New York City. Leaders from around the world in the field of Reproductive Medicine met to exchange ideas and debate controversial issues pertaining to infertility, and reproductive endocrine disorders.  In this blog post we provide a brief overview of some of the highlights of the symposium.